TY  - GEN
AB  - Melanoma is one of the more aggressive skin cancers with a high mortality rate once it metastasizes. New breakthroughs in the treatment of melanoma have come from the introduction of immune checkpoint blockade (ICB).
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
AU  - Seifert, Hilary
AU  - Fankhauser, Reilly
AU  - Meza-Romero, Roberto
AU  - DePatie, Nicholas
AU  - Fuiten, Allison
AU  - Offner, Halina
AU  - Vandenbark, Arthur A.
AU  - Kulkarni, Rajan
DA  - 2020
DO  - 10.6083/2z10wq80v
DO  - DOI
ID  - 8380
KW  - Melanoma
KW  - Immunotherapy
KW  - mif
KW  - cd74
KW  - drq
KW  - skin cancer
KW  - macrophage inhibitory factor
KW  - immune checkpoint inhibitors
L1  - https://digitalcollections.ohsu.edu/record/8380/files/ResearchWeek.2020.Seifert.Hilary.pdf
L2  - https://digitalcollections.ohsu.edu/record/8380/files/ResearchWeek.2020.Seifert.Hilary.pdf
L4  - https://digitalcollections.ohsu.edu/record/8380/files/ResearchWeek.2020.Seifert.Hilary.pdf
LA  - eng
LK  - https://digitalcollections.ohsu.edu/record/8380/files/ResearchWeek.2020.Seifert.Hilary.pdf
N2  - Melanoma is one of the more aggressive skin cancers with a high mortality rate once it metastasizes. New breakthroughs in the treatment of melanoma have come from the introduction of immune checkpoint blockade (ICB).
PB  - Oregon Health and Science University
PY  - 2020
T1  - A novel treatment for melanoma: targeting the MIF/CD74 inflammatory pathway
TI  - A novel treatment for melanoma: targeting the MIF/CD74 inflammatory pathway
UR  - https://digitalcollections.ohsu.edu/record/8380/files/ResearchWeek.2020.Seifert.Hilary.pdf
Y1  - 2020
ER  -